PL1812459T3 - Sposób wytwarzania w skali masowej multimerycznej lektyny wiążącej mannozę - Google Patents

Sposób wytwarzania w skali masowej multimerycznej lektyny wiążącej mannozę

Info

Publication number
PL1812459T3
PL1812459T3 PL04793596T PL04793596T PL1812459T3 PL 1812459 T3 PL1812459 T3 PL 1812459T3 PL 04793596 T PL04793596 T PL 04793596T PL 04793596 T PL04793596 T PL 04793596T PL 1812459 T3 PL1812459 T3 PL 1812459T3
Authority
PL
Poland
Prior art keywords
mbl
production
cell line
relates
multimeric
Prior art date
Application number
PL04793596T
Other languages
English (en)
Inventor
Hong Mo Moon
Jung Sun Yum
Byung Cheol Ahn
Joo Youn Lee
Jaeseung Yoon
Original Assignee
Dobeel Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dobeel Co Ltd filed Critical Dobeel Co Ltd
Publication of PL1812459T3 publication Critical patent/PL1812459T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726Lectins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4724Lectins
PL04793596T 2004-10-28 2004-10-28 Sposób wytwarzania w skali masowej multimerycznej lektyny wiążącej mannozę PL1812459T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/KR2004/002739 WO2006046786A1 (en) 2004-10-28 2004-10-28 Method for the mass production of multimeric mannose binding lectin
EP04793596A EP1812459B1 (en) 2004-10-28 2004-10-28 Method for the mass production of multimeric mannose binding lectin

Publications (1)

Publication Number Publication Date
PL1812459T3 true PL1812459T3 (pl) 2011-09-30

Family

ID=36228005

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04793596T PL1812459T3 (pl) 2004-10-28 2004-10-28 Sposób wytwarzania w skali masowej multimerycznej lektyny wiążącej mannozę

Country Status (10)

Country Link
EP (1) EP1812459B1 (pl)
JP (1) JP4592756B2 (pl)
AT (1) ATE503766T1 (pl)
BR (1) BRPI0419151A (pl)
DE (1) DE602004032062D1 (pl)
DK (1) DK1812459T3 (pl)
ES (1) ES2360504T3 (pl)
MX (1) MX2007005107A (pl)
PL (1) PL1812459T3 (pl)
WO (1) WO2006046786A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100836745B1 (ko) * 2007-01-31 2008-06-10 (주)두비엘 Hbv 백신 및 그의 제조 방법
JP5071940B2 (ja) * 2008-12-25 2012-11-14 独立行政法人産業技術総合研究所 抗真菌剤
DK2526119T3 (en) 2010-01-19 2018-07-30 Harvard College Manipulated opsonin for pathogen detection and treatment
WO2013012924A2 (en) 2011-07-18 2013-01-24 President And Fellows Of Harvard College Engineered microbe-targeting molecules and uses thereof
CN104284984B (zh) 2012-02-29 2017-10-13 哈佛大学校长及研究员协会 抗生素药敏性的快速测试
US10551379B2 (en) 2013-03-15 2020-02-04 President And Fellows Of Harvard College Methods and compositions for improving detection and/or capture of a target entity
AU2014268603B2 (en) 2013-05-21 2018-03-22 President And Fellows Of Harvard College Engineered heme-binding compositions and uses thereof
EP3912986B1 (en) 2013-12-18 2023-12-13 President and Fellows of Harvard College Crp capture/detection of bacteria
CN108289928A (zh) 2015-08-06 2018-07-17 哈佛大学校长及研究员协会 改进的微生物-结合分子和其用途
CA3207352A1 (en) 2021-02-08 2022-08-11 Alberto Mantovani Molecules for use in the treatment and/or prevention of covid-19

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6337193B1 (en) * 1998-11-24 2002-01-08 Aptagen, Inc. Expression of manose-binding protein in methylotrophic yeast
US6589534B1 (en) * 1999-09-30 2003-07-08 Yeda Research And Development Co., Ltd. Hepatitis B virus binding proteins and uses thereof
KR100408844B1 (ko) * 2000-07-29 2003-12-06 한국산업기술평가원 동물세포 발현벡터
WO2003010188A1 (en) * 2001-07-23 2003-02-06 Natimmune A/S Production of high molecular mass lectins
JP4051030B2 (ja) * 2001-08-31 2008-02-20 扶桑薬品工業株式会社 ヒトマンノース結合レクチンの精製方法、ヒトマンノース結合レクチン組成物およびヒトマンノース結合レクチンの医薬用途
KR100755931B1 (ko) * 2003-06-11 2007-09-06 (주)두비엘 고분자형 만노스 결합형 렉틴의 대량 생산방법 및 상기방법으로 제조된 만노스 결합형 렉틴 재조합 단백질의제제화

Also Published As

Publication number Publication date
EP1812459A4 (en) 2008-10-01
ATE503766T1 (de) 2011-04-15
DE602004032062D1 (de) 2011-05-12
EP1812459A1 (en) 2007-08-01
JP2008517619A (ja) 2008-05-29
EP1812459B1 (en) 2011-03-30
DK1812459T3 (da) 2011-05-23
ES2360504T3 (es) 2011-06-06
WO2006046786A1 (en) 2006-05-04
JP4592756B2 (ja) 2010-12-08
MX2007005107A (es) 2007-09-11
BRPI0419151A (pt) 2007-12-11

Similar Documents

Publication Publication Date Title
NZ591415A (en) Haemophilus influenzae type B
WO2005112597A3 (en) Transgenic plants expressing intein modified proteins and associated processes for bio-pharmaceutical production
DE60228460D1 (de) Verfahren zur Herstellung und Reinigung von Erythropoietin
PL1812459T3 (pl) Sposób wytwarzania w skali masowej multimerycznej lektyny wiążącej mannozę
MX2007003906A (es) Metodos y composiciones para mejorar la produccion de proteinas recombinantes.
WO2006050270A3 (en) Compositions and methods for treating hyperproliferative disorders
WO2003029403A3 (en) Targeting proteins to cells expressing mannose receptors via expression in insect cells
ATE301715T1 (de) Durch molekulares pathogenicid vermittelte krankheitsresistenz in pflanzen
MX336807B (es) Composiciones y metodos para producir una composicion.
EP2508613A3 (en) Glycosylation of molecules
TW200606177A (en) Glycoprotein VI antibodies and methods thereof
NZ599598A (en) Hyperblebbing shigella strains
SG149061A1 (en) Definitive endoderm
ATE527349T1 (de) Nervenregeneration
MX348154B (es) Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
WO2007110231A3 (en) MODIFIED INTERFERON-β (IFN-β) POLYPEPTIDES
AR071232A1 (es) Proteina hibrida usada como vacuna contra toxinas shiga de e. coli
NZ603805A (en) Methods for increasing and mobilizing hematopoietic stem cells
AU2003304250A1 (en) Method of isolating cells from umbilical cord
UA95446C2 (ru) Мутаци в генах oas1
MY157947A (en) Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
SI1675956T1 (sl) Minimalno zaporedje dna, ki deluje kot izolirni element kromatina in njegova uporaba pri ekspresiji proteinov
IL138615A0 (en) Alphaviral gene expression system and dna molecules for use therein
WO2003040681A3 (de) Gene die für stoffwechselweg-proteine codieren
ATE500840T1 (de) Verwendung von gilz-protein zur modulation einer antigenspezifischen immunantwort